403 participants
A Clinical Trial of Patients With Solid Tumours Receiving Granulocyte Colony Stimulating Factor as Primary Prophylaxis for Chemotherapy-induced Neutropenia, in a Docetaxel Based Regimen
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2012-10-05
- Start Date:
- 2010-03-31
- Completion:
- 2012-07-31
Conditions
- Neoplasms (no Otherwise Specified)
Interventions
- DRUG
No Results Yet